Phrenos Pharma Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
- Paid Up Capital ₹ 1.89 M
- Company Age 17 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -15.01%
- Profit Growth -8.61%
- Ebitda -7.03%
- Net Worth 14.17%
- Total Assets 2.13%
About Phrenos Pharma
Phrenos Pharma Private Limited (PPPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 November 2007 and has a history of 17 years and two months. Its registered office is in Kanyakumari, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 1.89 M, as per Ministry of Corporate Affairs (MCA) records.
Bhaskar Chandrasekaran, Padmanabhan, Ramanujam Sreenivas, and Seven other members serve as directors at the Company.
Company Details
- Location
Kanyakumari, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24230TN2007PTC065377
- Company No.
065377
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Nov 2007
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Phrenos Pharma?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sughie Ravichandar  | Managing Director | 14-Nov-2007 | Current |
| Carlius Prakash | Managing Director | 14-Nov-2007 | Current |
Board Members (8)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Bhaskar Chandrasekaran | Director | 14-Nov-2007 | Current |
| Padmanabhan | Director | 14-Nov-2007 | Current |
| Ramanujam Sreenivas | Director | 14-Nov-2007 | Current |
| Arunachalam Venkateswaran | Director | 14-Nov-2007 | Current |
| Kasi Kanesalingavelan | Director | 14-Nov-2007 | Current |
| Setlin Venkatesh | Director | 14-Nov-2007 | Current |
Financial Performance of Phrenos Pharma.
Phrenos Pharma Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 15.01% decrease. The company also saw a slight decrease in profitability, with a 8.61% decrease in profit. The company's net worth Soared by an impressive increase of 14.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Phrenos Pharma?
In 2021, Phrenos Pharma had a promoter holding of 79.58% and a public holding of 20.42%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Psymed Hospitals Private LimitedSetlin Venkatesh is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Phrenos Pharma?
Unlock and access historical data on people associated with Phrenos Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Phrenos Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Phrenos Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.